Covid-19 roundup: Dai­ichi's mR­NA shot en­ters the clin­ic; South Africa sells its As­traZeneca sup­ply to neigh­bors

An­oth­er mR­NA-based vac­cine is en­ter­ing the clin­ic.

Over a year af­ter Mod­er­na kicked off tri­als for their mR­NA-based Covid-19 shot, Japan­ese drug­mak­er Dai­ichi-Sankyo an­nounced …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.